Emerging Antimicrobials and Diagnostics 2022 is made possible by our esteemed partners:
Innovate UK is the UK’s national innovation agency. We support business-led innovation in all sectors, technologies and UK regions. We help businesses grow through the development and commercialisation of new products, processes, and services, supported by an outstanding innovation ecosystem that is agile, inclusive, and easy to navigate.
Addressing the human health impacts of AMR will require building a strong and motivated coalition of like-minded health officials, clinicians, laboratorians, policymakers, patients and leaders.
Evotec is a life science company with a unique business model focused on delivering highly effective new therapeutics to the patients. The Company leverages its multimodality platform, the “Data-driven R&D Autobahn to Cures”, for proprietary projects and within a network of partners including Pharma, Biotech, academics, and other healthcare stakeholders. With more than 4,200 highly qualified people at 15 sites, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics. For additional information please go to www.evotec.com and follow us on Twitter @Evotec and LinkedIn.
Molzym is committed to the development of innovative solutions to serve biological research and diagnosis of infectious diseases. Its developmental efforts are focused on new processes enabling and facilitating the molecular diagnosis of infectious diseases caused by bacteria and fungi.
JSS Academy of Higher Education & Research was founded in the year 2008 on the principles of pursuing and nurturing research oriented higher education for the benefit of the society we serve. JSS Academy of Higher Education & Research is made up of 6 faculty Faculty of Medicine, Faculty of Dentistry, Faculty of Pharmacy, Faculty of Bio-medical Sciences , Faculty of Life Sciences , Faculty of Health System Management Studies.
NYtor (2007) designs and (co-)develops smart, molecular assays for detecting antibiotic resistance in human and veterinary diagnostics. Design and co-development take place in close collaboration with customers, selected suppliers and global partners. NYtor also produces its prototype assays.